🌎 CRH Initiated, Repligen Initiated, RB Global Initiated and more…
RJ Hamster
Ratings changes for NVIDIA, Vanda Pharmaceuticals, Automatic Data Processing, PayPal, Apple, Intel, Zentalis Pharmaceuticals and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports.Learn More.
Obama’s Forever Term [Exposed] or Obama Biden has already won 2024
Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.
Apple (NASDAQ:AAPL) had its price target raised by analysts at JPMorgan Chase & Co. () from $225.00 to $245.00. They now have an “overweight” rating on the stock. This represents a 14.4% upside from the current price of $214.22.
Apple was the recipient of unusually large options trading activity on Monday. Stock traders bought 1,423,490 call options on the company. This is an increase of approximately 28% compared to the typical volume of 1,110,504 call options.
CEO Mark Zuckerberg sold 16,702 shares of Meta Platforms stock in a transaction on Friday, June 14th. The shares were sold at an average price of $503.34, for a total transaction of $8,406,784.68. Following the transaction, the chief executive officer now owns 275,297 shares in the company, valued at approximately $138,567,991.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
COO Javier Olivan sold 412 shares of Meta Platforms stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $505.75, for a total transaction of $208,369.00. Following the transaction, the chief operating officer now owns 8,031 shares in the company, valued at approximately $4,061,678.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Juniper Networks (NYSE:JNPR) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $40.00 price target on the stock. This represents a 12.6% upside from the current price of $35.51.
Kroger (NYSE:KR) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $60.00 price target on the stock, up previously from $58.00. This represents a 15.5% upside from the current price of $51.93.
QuinStreet (NASDAQ:QNST) was upgraded by analysts at Craig Hallum from a “hold” rating to a “buy” rating. They now have a $22.00 price target on the stock. This represents a 31.1% upside from the current price of $16.78.
STMicroelectronics (NYSE:STM) was upgraded by analysts at The Goldman Sachs Group, Inc. from a “sell” rating to a “neutral” rating. They now have a $45.80 price target on the stock, up previously from $35.50. This represents a 6.3% upside from the current price of $43.10.
Sunoco (NYSE:SUN) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $65.00 price target on the stock. This represents a 18.1% upside from the current price of $55.02.
Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $2.00 price target on the stock, down previously from $35.00. This represents a 33.8% upside from the current price of $1.50.
Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating.The current price is $1.50.
Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “inline” rating. They now have a $2.00 price target on the stock, down previously from $27.00. This represents a 33.8% upside from the current price of $1.50.
Equitable (NYSE:EQH) was downgraded by analysts at UBS Group AG from a “buy” rating to a “neutral” rating. They now have a $43.00 price target on the stock, up previously from $40.00. This represents a 7.6% upside from the current price of $39.95.
First Solar (NASDAQ:FSLR) was downgraded by analysts at Janney Montgomery Scott from a “buy” rating to a “neutral” rating.The current price is $261.25.
Ovid Therapeutics (NASDAQ:OVID) was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating.The current price is $0.84.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating.The current price is $5.51.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at Wedbush from a “neutral” rating to an “underperform” rating. They now have a $4.00 price target on the stock, down previously from $15.00. This represents a 27.4% downside from the current price of $5.51.
Autoliv (NYSE:ALV) is now covered by analysts at BNP Paribas. They set a “neutral” rating on the stock.The current price is $109.49.
Amerant Bancorp (NASDAQ:AMTB) is now covered by analysts at Janney Montgomery Scott. They set a “buy” rating and a $25.00 price target on the stock. This represents a 16.6% upside from the current price of $21.44.
Cardlytics (NASDAQ:CDLX) is now covered by analysts at Northland Securities. They set an “outperform” rating and a $14.00 price target on the stock. This represents a 71.8% upside from the current price of $8.15.
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $58.00 price target on the stock. This represents a 64.9% upside from the current price of $35.17.
CRH (NYSE:CRH) is now covered by analysts at Stephens. They set an “overweight” rating and a $95.00 price target on the stock. This represents a 22.1% upside from the current price of $77.83.
Innoviva (NASDAQ:INVA) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating on the stock.The current price is $16.36.
Knife River (NYSE:KNF) is now covered by analysts at Stephens. They set an “overweight” rating and a $85.00 price target on the stock. This represents a 20.7% upside from the current price of $70.41.
Kopin (NASDAQ:KOPN) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $2.50 price target on the stock. This represents a 242.7% upside from the current price of $0.73.
Omega Therapeutics (NASDAQ:OMGA) is now covered by analysts at Raymond James. They set an “outperform” rating and a $12.00 price target on the stock. This represents a 476.9% upside from the current price of $2.08.
Pilgrim’s Pride (NASDAQ:PPC) is now covered by analysts at Argus. They set a “buy” rating and a $41.00 price target on the stock. This represents a 17.0% upside from the current price of $35.05.
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Guggenheim. They set a “buy” rating and a $155.00 price target on the stock. This represents a 297.4% upside from the current price of $39.00.
RB Global (NYSE:RBA) (TSE:RBA) is now covered by analysts at CIBC. They set a “sector outperform” rating on the stock.The current price is $81.25.
Repligen (NASDAQ:RGEN) is now covered by analysts at Guggenheim. They set a “neutral” rating on the stock.The current price is $123.04.
Sportradar Group (NASDAQ:SRAD) is now covered by analysts at JPMorgan Chase & Co.. They set a “neutral” rating and a $12.00 price target on the stock. This represents a 12.3% upside from the current price of $10.69.
TF Financial (NASDAQ:THRD) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $23.00 price target on the stock. This represents a 77.6% upside from the current price of $12.95.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat’s free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
